S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
WARNING TO ALL U.S. INVESTORS (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
WARNING TO ALL U.S. INVESTORS (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
WARNING TO ALL U.S. INVESTORS (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
WARNING TO ALL U.S. INVESTORS (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
OTCMKTS:CTTC

Calmare Therapeutics (CTTC) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CTTC stock logo

About Calmare Therapeutics (OTCMKTS:CTTC) Stock

Calmare Therapeutics, Inc. engages in the research, development, and commercialization of chronic, neuropathic pain and wound affliction devices. It offers licensing and technology sourcing. The company was founded in 1968 and is headquartered in Fairfield, CT.

Receive CTTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calmare Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CTTC Stock News Headlines

United Therapeutics Corp UTHR Stock Quote
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser
Small cap wins $1.65 billion contract to make them. GlobeNewswire says this is a $51.1 Billion market by 2026. See why this stock could soar 2,476% >>>
Calmare Therapeutics Inc (CTTC)
Calmare Therapeutics Inc.
News for Calmare Therapeutics Inc
Calmare Therapeutics Inc
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Calmare Therapeutics Incorporated (CTTC)
Calmare Therapeutics CEO Issues Statement
See More Headlines

Receive CTTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calmare Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CTTC Company Calendar

Today
5/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CTTC
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.27

Key Executives

  • Conrad F. Mir
    President, Chief Executive Officer & Director
  • Thomas P. Richtarich
    Chief Financial Officer
  • Stephen J. D'Amato
    Chief Medical Officer
  • Donna J. Mays
    Manager-Administrative Services
  • William Lipford
    Head-Product Sales













CTTC Stock - Frequently Asked Questions

What other stocks do shareholders of Calmare Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calmare Therapeutics investors own include Idera Pharmaceuticals (IDRA), Brainstorm Cell Therapeutics (BCLI), Costco Wholesale (COST), Blue Apron (APRN), Arista Networks (ANET), Amgen (AMGN), Advanced Micro Devices (AMD), Akers Biosciences (AKER) and Enact (ACT).

What is Calmare Therapeutics' stock symbol?

Calmare Therapeutics trades on the OTCMKTS under the ticker symbol "CTTC."

How do I buy shares of Calmare Therapeutics?

Shares of CTTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How can I contact Calmare Therapeutics?

Calmare Therapeutics' mailing address is 1375 KINGS HIGHWAY EAST SUITE 400, FAIRFIELD CT, 06824. The official website for the company is www.calmaretherapeutics.com. The company can be reached via phone at (203) 368-6044, via email at ctt@calmaretherapeutics.com, or via fax at 203-368-5399.

This page (OTCMKTS:CTTC) was last updated on 5/27/2023 by MarketBeat.com Staff

My Account -